Please login or register first to view this content.
Allergic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Discontinuing Mepolizumab Decreases Asthma Control, Increases Eosinophil Counts
Boxed Warning Added to Montelukast Labeling Regarding Neuropsychiatric Events
Zerviate Ophthalmic Solution Now Available for Allergic Conjunctivitis
ACAAI: Statement on Corticosteroid Use for Allergies, Asthma During COVID-19 Pandemic
Potential EpiPen Device Failure, Use Errors Detailed in Letter to HCPs
First US Patients Receive Palforzia as Long-Term Data Show Improved Peanut Tolerability
Hereditary Angioedema Monthly Attack Rates Decreased With Addition of Lanadelumab
Prenatal Exposure to Antacids Increases Food Protein-Induced Allergic Proctocolitis Risk
Epinephrine More Commonly Used for Venom and Anaphylaxis Than Food Allergy
Ragweed SLIT Tablets Effective in Pediatric Allergic Rhinitis With Conjunctivitis
FDA Strengthens Warning About Risk of Neuropsychiatric Events With Montelukast
FDA Approves First Treatment for Peanut Allergy
Inhaled Itraconazole Fast-Tracked for Allergic Bronchopulmonary Aspergillosis in Asthma
The FDA Approval Process Needs Refinement, Not a Total Overhaul
Long-Term Data Support Benefits of Viaskin Peanut Patch
Berotralstat NDA for Hereditary Angioedema Prophylaxis Submitted to FDA
FDA: Do Not Use Products Distributed by Basic Reset, Biogenyx
Corticosteroids Compared for Pre-Infusion Prophylaxis in Patients Receiving Pegloticase for Gout
